CARBINOXAMINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
When do Carbinoxamine Maleate patents expire, and when can generic versions of Carbinoxamine Maleate launch?
Carbinoxamine Maleate is a drug marketed by Cypress Pharm, Genus, Vintage Pharms, Invagen Pharms, Mikart, Mission Pharmacal, and Strides Pharma. and is included in nine NDAs.
The generic ingredient in CARBINOXAMINE MALEATE is carbinoxamine maleate. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Carbinoxamine Maleate
A generic version of CARBINOXAMINE MALEATE was approved as carbinoxamine maleate by GENUS on March 19th, 2003.
Summary for CARBINOXAMINE MALEATE
Pharmacology for CARBINOXAMINE MALEATE
Drug Class | Histamine-1 Receptor Antagonist |
Mechanism of Action | Histamine H1 Receptor Antagonists |